Dr. Aman Garsa, MD

Dr. Garsa practices at Texas Oncology PA in Dallas, Texas.

Dr. Garsa's NPI, 1821296047, was assigned on July 10, 2007. Dr. Garsa graduated from Pt. B.D. Sharma Postgrad Institute of Medical Science in 2003. Dr. Garsa holds Texas license U4205.

Dr. Garsa's primary practice is Texas Oncology PA, at 3410 Worth St, Dallas, TX 75246 in Dallas County. The practice phone is (972) 997-8000.

Dr. Garsa's primary practice is Texas Oncology PA in Dallas, Texas. Dr. Garsa is also affiliated with Methodist Dallas Medical Center. The medical group on file is Texas Oncology. Dmand AI also links Dr. Garsa to 1 more hospital, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Garsa practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Garsa's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Garsa is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Garsa's licenses on file in 4 states: Texas, Oklahoma, Tennessee and Pennsylvania.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, lung cancer, lymphoma, neutropenia and purpura and thrombocytopenia among the conditions Dr. Garsa treats.

CMS data shows 330 Medicare services from Dr. Garsa across 8 procedure codes in 2024, for 171 Medicare patients. Medicare paid $9,201 for them. Every service was in an office.

CMS counts 171 Medicare patients who saw Dr. Garsa in 2024. The largest group is 65 to 74, with 73 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 2.06, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Garsa's median patient age at 66, with 57% women.

In 2024, Dr. Garsa wrote 61 Medicare Part D claims for 28 patients. 72% of them were for generic drugs. CMS names the drug for 51 of them, across 3 drugs with 11 or more claims each, at $304,214 in total drug cost. In 2022, CMS named 164 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 77 out of 100 for Dr. Garsa for performance year 2024, reported as part of a group. Dr. Garsa accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 866 general payments to Dr. Garsa from 73 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 94% of the total. AstraZeneca Pharmaceuticals LP paid the most, $1,363.

Dr. Garsa graduated from Pt. B.D. Sharma Postgrad Institute of Medical Science in 2003. Dr. Garsa is a member of ASCO.

Dr. Garsa is in network with 22 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.